1-7 of 7
Michael J. Kelley
Close
Sort by
Journal Articles

Tolerability and Outcomes of Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia in Patients with Severe Renal Dysfunction

Chenyu Lin, Clare E Anderson, Micaela R Scobie, Thomas D Rodgers, Michael J Kelley, Daphne R Friedman
Journal: Blood
Blood (2023) 142 (Supplement 1): 4648.
https://doi.org/10.1182/blood-2023-178142
Published: 2023
Journal Articles

Impact of Social Determinants of Health and Novel Therapies on the Outcomes of Relapsed and Refractory Diffuse Large B Cell Lymphoma

Chenyu Lin, Micaela R Scobie, Clare E Anderson, Daphne R Friedman, Michael J Kelley, Thomas D Rodgers
Journal: Blood
Blood (2023) 142 (Supplement 1): 2396.
https://doi.org/10.1182/blood-2023-178803
Published: 2023
Journal Articles

Utilization of Pharmacogenomics in Assessment of Tolerability and Efficacy of BTK Inhibitors

Fahmin Basher, Micaela R. Scobie, Michael J. Kelley, Deepak Voora, Daphne R. Friedman
Journal: Blood
Blood (2022) 140 (Supplement 1): 11573–11574.
https://doi.org/10.1182/blood-2022-170301
Published: 2022
Journal Articles

Prolymphocytic Progression of Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: A Nationwide Veterans Affairs Retrospective Review

Chenyu Lin, Micaela R. Scobie, Daphne R. Friedman, Michael J. Kelley, Thomas D. Rodgers
Journal: Blood
Blood (2022) 140 (Supplement 1): 4176–4177.
https://doi.org/10.1182/blood-2022-157414
Published: 2022
Journal Articles

Mouse models of MYH9 -related disease: mutations in nonmuscle myosin II-A

Yingfan Zhang, Mary Anne Conti, Daniela Malide, Fan Dong, Aibing Wang, Yelena A. Shmist, Chengyu Liu, Patricia Zerfas, Mathew P. Daniels, Chi-Chao Chan, Elliot Kozin, Bechara Kachar, Michael J. Kelley, Jeffrey B. Kopp, Robert S. Adelstein
Journal: Blood
Blood (2012) 119 (1): 238–250.
https://doi.org/10.1182/blood-2011-06-358853
Published: 2012
Includes: Multimedia, Supplemental data
Journal Articles

Erythropoietin and Erythropoietin Receptor Expression in Early Stage Non-Small Cell Lung Cancer: Prognostic Significance.

Khalid Amin, MD, Zishan A. Haroon, MD, PhD, Seok J. Kim, MD, Sufeng Li, MD, Zahid N. Rabbani, MD, Robin T. Vollmer, MD, Xiaofei F. Wang, MD, Michael J. Kelley, MD, Murat O. Arcasoy, MD
Journal: Blood
Blood (2005) 106 (11): 4258.
https://doi.org/10.1182/blood.V106.11.4258.4258
Published: 2005
Journal Articles

Rod mutations associated with MYH9- related disorders disrupt nonmuscle myosin-IIA assembly

Josef D. Franke, Fan Dong, Wayne L. Rickoll, Michael J. Kelley, Daniel P. Kiehart
Journal: Blood
Blood (2005) 105 (1): 161–169.
https://doi.org/10.1182/blood-2004-06-2067
Published: 2005